1. PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. (23rd June 2022) Authors: Fonseca, R.; Chinaeke, E.; Gupta, N.; Fu, A.; Ran, T.; Kaila, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗